Peru Analgesics Market Report: Trends, Growth and Forecast (2026-2032)

By Product (Systemic Analgesics (Adult Analgesics, Paediatric Analgesics, Combined Systemic Analgesics), Topical Analgesics/Anaesthetic), By Drug Type (Opioid Analgesics (Strong Opioids, Weak Opioids), Non-opioid Analgesics (Acetaminophen, Aspirin, Combination Products, Diclofenac, Dipyrone, Ibuprofen, Ketoprofen, Naproxen, OTC Triptans), Compound/Combination Analgesics (Opioid + Non-Opioid Combinations, Multi-Ingredient Non-Opioid Combinations)), By Route of Administration (Oral, Parenteral/Injectable, Topical/External, Transdermal, Rectal/Other), By Pain Type (Acute Pain, Chronic Pain, Breakthrough Pain), By Application (Surgical & Post-operative Pain, Musculoskeletal Pain, Neuropathic Pain, Cancer Pain, Migraine/Headache, Dental Pain, Others), By Sales Channel (Retail Offline (Offline Pharmacies, Hospital Pharmacies), Retail Online (Online Pharmacies)), By Prescription Type (Prescription, OTC), By Formulation (Tablets, Capsules, Liquids, Injectables, Gels/Creams, Patches), By End User (Hospitals, Clinics/ASCs, Homecare) ... Read more

Report Code:
VI1669
Pages:
180
Category:
Healthcare
Formats:
PDF PPT Excel
Global
Countries
Australia
China
Egypt
France
India
Japan
Kenya
Malaysia
Mexico
Netherlands
Norway
Philippines
Poland
Saudi Arabia
Spain
Thailand
Turkey
UAE
UK
Vietnam
Peru Analgesics Market Report: Trends, Growth and Forecast (2026-2032)

Major Players

  • Maver Peru SAC
  • Medifarma SA
  • Farmindustria SA
  • GSK Consumer Healthcare Peru SRL
  • Hersil SA Laboratorios Industriales Farmaceuticos
  • Bayer SA

Peru Analgesics Market Statistics and Insights, 2026

  1. Market Size Statistics
    1. Analgesics market size in Peru was valued at USD 220 million in 2025 and is estimated at USD 225 million in 2026.
    2. The market size is expected to grow to USD 245 million by 2032.
    3. Market to register a CAGR of around 1.55% during 2026-32.
  2. Product Shares
    1. Systemic analgesics grabbed market share of 90%.
  3. Competition
    1. More than 10 companies are actively engaged in producing analgesics in Peru.
    2. Top 5 companies acquired around 45% of the market share.
    3. Maver Peru SAC, Medifarma SA, Farmindustria SA, GSK Consumer Healthcare Peru SRL, Hersil SA Laboratorios Industriales Farmaceuticos etc., are few of the top companies.
  4. Sales Channel
    1. Retail offline grabbed 95% of the market.

Peru Analgesics Market Outlook

Peru analgesics market size was valued at USD 220 million in 2025 and is projected to grow from USD 225 million in 2026 to USD 245 million by 2032, exhibiting a CAGR of 1.55% during the forecast period. The outlook remains steady as everyday pain and fever treatment stays important in Peru, supported by routine self care demand and regular need for quick symptom relief. Demand also remains visible because dengue continues to keep fever, headache, and body pain treatment relevant across the country.

A major support for future demand comes from continued need for accessible OTC pain relief, especially when consumers look for fast and familiar options at home. Peru’s Ministry of Health reports 247,097 dengue cases and 231 deaths in 2024, showing the wide health burden linked with fever and body pain. At the same time, branded analgesics continue to face pressure from lower cost alternatives, as Law No. 32033 requires private pharmacies and boticas to keep at least 30% of their offer in essential generic medicines in DCI, keeping affordability central in purchase decisions.

Product demand remains strongly concentrated in oral formats, with systemic analgesics holding around 90% of the market in value terms. This segment stays ahead because it fits the most common pain needs in Peru, including headache, fever, and general body pain. These analgesics are easy to use, widely understood by consumers, and practical for short term relief in daily self care.

Sales continue to be led by physical stores, with retail offline accounting for around 95% of the market in value terms. This channel remains dominant because buyers still rely on pharmacies and boticas for immediate access, quick purchase, and direct advice. DIGEMID reports 29,433 active private boticas and pharmacies as of 30 June 2025, which keeps offline access highly visible and supports continued store based buying of analgesics across Peru.

Donut chart showing market share of key players in the Peru analgesics market

Peru Analgesics Market Growth Driver

Rising Dengue Burden Keeps Pain Relief Relevant

Dengue continues to keep everyday pain and fever treatment highly visible in Peru. This supports steady need for OTC pain relief because the illness often begins with fever, headache, and body pain, pushing consumers to look for fast and familiar symptom control. For analgesics, this creates a clear demand base in routine self care, especially for products commonly used when people want quick relief at home.

The public health burden remains large. Peru’s Ministry of Health reports 247,097 dengue cases and 231 deaths in 2024, showing how wide the disease impact remains across the country. When this level of dengue circulation stays present, the need for accessible pain relief remains visible in daily medicine buying, helping keep demand firm for products used for fever and general body discomfort.

Peru Analgesics Market Challenge

Wider Generic Availability Pressures Branded Pricing

Branded analgesics face stronger pricing pressure in Peru because the policy environment now gives more support to generics. This makes it harder for higher priced products to stand out, especially in a category where consumers often buy for common pain episodes and compare value carefully. As generic options become easier to find and easier to recommend, price competition remains a real challenge for branded players.

Law No. 32033 states that private pharmacies and boticas must keep available at least 30% of their brand offer in the alternative of essential generic medicines in DCI. The same law also prohibits incentives that push pharmacy staff to steer buyers toward certain brands over generics. This keeps affordability at the center of purchase decisions and raises the pressure on branded analgesics to justify a higher price.

Unlock Market Intelligence

Explore the market potential with our data-driven report

Get Sample Pages →

Peru Analgesics Market Trend

Digital Comparison Shapes Purchase Discovery

A clearer shift in Peru is the stronger role of digital access in how consumers discover and compare medicines. As more households stay connected, people can check options, compare prices, and review alternatives before purchase. This makes product visibility, price communication, and simple messaging more important for analgesics, especially when buyers want faster decisions for common pain problems.

National Institute of Statistics and Informatics (INEI) says 95.4% of Peruvian households have mobile access and 60.1% have internet service in the second quarter of 2025. At the same time, Law No. 32033 says the obligation to offer generic alternatives applies in all sales channels, including virtual or digital channels, and pharmacies must provide updated price information to the national medicines price system. This makes digital comparison more relevant in medicine choice.

Peru Analgesics Market Opportunity

More Active Lifestyles Create Room for Topical Relief

More organised exercise and community sports activity create stronger room for pain relief used after strain, cramps, and muscle discomfort. This is especially supportive for topical formats because they match short term, localised pain needs linked with movement and recreation. As more people take part in sports or activity led programmes, the use case for quick application pain relief becomes easier for brands to build around.

The Instituto Peruano del Deporte says 32,202 students join the 2026 summer season of Academia Peruvian Institute of Sport (IPD) across 37 disciplines and 71 sports complexes nationwide. In addition, the IPD says its Vida Saludable programme has already benefited more than 7,700 people, with 19 technical assistances delivered to municipalities. This broader activity base creates better space for topical analgesics linked with sprains, post exercise soreness, and muscle pain.

Unlock Market Intelligence

Explore the market potential with our data-driven report

Get Sample Pages →

Peru Analgesics Market Segmentation Analysis

By Product

  • Systemic Analgesics
    • Adult Analgesics
    • Paediatric Analgesics
    • Combined Systemic Analgesics
  • Topical Analgesics/Anaesthetic

The segment with the highest share around 90% under the product is systemic analgesics. This segment stays ahead because oral pain relief fits the most common everyday needs in Peru, including fever, headache, and body pain. These products are easy to use, widely understood by consumers, and practical for routine self care when people want a fast and familiar option for short term symptom control.

Its leading position also aligns with the country’s recent disease burden. Peru’s Ministry of Health reports 247,097 dengue cases and 231 deaths in 2024, keeping fever and body pain treatment highly relevant. Systemic analgesics are well placed in this setting because they are commonly used when consumers need relief that works across multiple symptoms rather than only one local pain point.

Pie chart showing Peru analgesics market segmentation by product and sales channel

By Sales Channel

  • Retail Offline
    • Offline Pharmacies
    • Hospital Pharmacies
  • Retail Online
    • Online Pharmacies

The segment with the highest share around 95% under the sales channel is retail offline. This channel leads because medicines in Peru are still mainly bought through physical pharmacies and boticas, where consumers get immediate access, quick purchase, and direct guidance at the point of sale. For analgesics, that matters because many purchases are urgent and linked to same day symptom relief.

General Directorate of Medicines, Supplies, and Drugs (DIGEMID) says Peru has 29,433 active private boticas and pharmacies as of 30 June 2025. It also says that in the first half of 2025, 81.4% of newly authorised private pharmaceutical establishments correspond to boticas and pharmacies. This wide physical network keeps store based access highly visible and helps retail offline remain the main channel for analgesics across the country.

List of Companies Covered in Peru Analgesics Market

The companies listed below are highly influential in the Peru analgesics market, with a significant market share and a strong impact on industry developments.

  • Maver Peru SAC
  • Medifarma SA
  • Farmindustria SA
  • GSK Consumer Healthcare Peru SRL
  • Hersil SA Laboratorios Industriales Farmaceuticos
  • Bayer SA
  • Pfizer SA
  • Teva Peru SA
  • Vita Pharma SAC

Competitive Landscape

In 2025, the market for OTC analgesics in Peru showed mixed performance, influenced by economic pressures, dengue outbreaks, and increased self-medication trends. GSK Consumer Healthcare Perú SRL led the market with a 24.9% value share, followed by Hersil SA Laboratorios Industriales Farmacéuticos at 7.8%. Generics gained traction due to their affordability, while branded acetaminophen maintained strong consumer awareness. Ibuprofen remained stable, and topical analgesics benefited from increased physical activity and health-conscious lifestyles. Aspirin experienced declining retail sales as more consumers accessed it through insurance for cardiac prevention. The regulatory landscape, including Law No. 32033, mandated pharmacies to offer at least 30% of essential generics and restricted promotional incentives, further supporting generics growth. Consumers continued self-medicating for stress, headaches, and mild pain, creating opportunities for combination OTC products emphasizing fast-acting relief, while advertising and packaging communications remained key tools to influence purchase decisions.

Frequently Asked Questions

   A. Peru analgesics market is anticipated to register a CAGR of approximately 1.55% during the forecast period.

   A. Market size of Peru analgesics market in 2025 was valued at around USD 220 Million.

   A. Rising dengue burden keeps pain relief relevant is a key factor driving the growth of the analgesics in Peru.

   A. Systemic analgesics held the largest market share by value in Peru analgesics market in 2025.

   A. More active lifestyles create room for topical relief represents a significant growth opportunity for the Peru analgesics market.

   A. Wider generic availability pressures branded pricing continues to pose a major challenge for the Peru analgesics market.

   A. Digital comparison shapes purchase discovery stands out as a prominent trend boosting the growth of the Peru analgesics market.
  1. Market Segmentation
    1. Research Scope
    2. Research Methodology
    3. Definitions and Assumptions
  2. Executive Summary
  3. Peru Analgesics Market Policies, Regulations, and Standards
  4. Peru Analgesics Market Dynamics
    1. Growth Factors
    2. Challenges
    3. Trends
    4. Opportunities
  5. Peru Analgesics Market Statistics, 2022-2032F
    1. Market Size & Growth Outlook
      1. By Revenues in USD Million
    2. Market Segmentation & Growth Outlook
      1. By Product
        1. Systemic Analgesics- Market Insights and Forecast 2022-2032, USD Million
          1. Adult Analgesics- Market Insights and Forecast 2022-2032, USD Million
          2. Paediatric Analgesics- Market Insights and Forecast 2022-2032, USD Million
          3. Combined Systemic Analgesics- Market Insights and Forecast 2022-2032, USD Million
        2. Topical Analgesics/Anaesthetic- Market Insights and Forecast 2022-2032, USD Million
      2. By Drug Type
        1. Opioid Analgesics- Market Insights and Forecast 2022-2032, USD Million
          1. Strong Opioids- Market Insights and Forecast 2022-2032, USD Million
          2. Weak Opioids- Market Insights and Forecast 2022-2032, USD Million
        2. Non-opioid Analgesics- Market Insights and Forecast 2022-2032, USD Million
          1. Acetaminophen- Market Insights and Forecast 2022-2032, USD Million
          2. Aspirin- Market Insights and Forecast 2022-2032, USD Million
          3. Combination Products- Market Insights and Forecast 2022-2032, USD Million
          4. Diclofenac- Market Insights and Forecast 2022-2032, USD Million
          5. Dipyrone- Market Insights and Forecast 2022-2032, USD Million
          6. Ibuprofen- Market Insights and Forecast 2022-2032, USD Million
          7. Ketoprofen- Market Insights and Forecast 2022-2032, USD Million
          8. Naproxen- Market Insights and Forecast 2022-2032, USD Million
          9. OTC Triptans- Market Insights and Forecast 2022-2032, USD Million
        3. Compound/Combination Analgesics- Market Insights and Forecast 2022-2032, USD Million
          1. Opioid + Non-Opioid Combinations- Market Insights and Forecast 2022-2032, USD Million
          2. Multi-Ingredient Non-Opioid Combinations- Market Insights and Forecast 2022-2032, USD Million
      3. By Route of Administration
        1. Oral- Market Insights and Forecast 2022-2032, USD Million
        2. Parenteral/Injectable- Market Insights and Forecast 2022-2032, USD Million
        3. Topical/External- Market Insights and Forecast 2022-2032, USD Million
        4. Transdermal- Market Insights and Forecast 2022-2032, USD Million
        5. Rectal/Other- Market Insights and Forecast 2022-2032, USD Million
      4. By Pain Type
        1. Acute Pain- Market Insights and Forecast 2022-2032, USD Million
        2. Chronic Pain- Market Insights and Forecast 2022-2032, USD Million
        3. Breakthrough Pain- Market Insights and Forecast 2022-2032, USD Million
      5. By Application
        1. Surgical & Post-operative Pain- Market Insights and Forecast 2022-2032, USD Million
        2. Musculoskeletal Pain- Market Insights and Forecast 2022-2032, USD Million
        3. Neuropathic Pain- Market Insights and Forecast 2022-2032, USD Million
        4. Cancer Pain- Market Insights and Forecast 2022-2032, USD Million
        5. Migraine/Headache- Market Insights and Forecast 2022-2032, USD Million
        6. Dental Pain- Market Insights and Forecast 2022-2032, USD Million
        7. Others- Market Insights and Forecast 2022-2032, USD Million
      6. By Sales Channel
        1. Retail Offline- Market Insights and Forecast 2022-2032, USD Million
          1. Offline Pharmacies- Market Insights and Forecast 2022-2032, USD Million
          2. Hospital Pharmacies- Market Insights and Forecast 2022-2032, USD Million
        2. Retail Online- Market Insights and Forecast 2022-2032, USD Million
          1. Online Pharmacies- Market Insights and Forecast 2022-2032, USD Million
      7. By Prescription Type
        1. Prescription- Market Insights and Forecast 2022-2032, USD Million
        2. OTC- Market Insights and Forecast 2022-2032, USD Million
      8. By Formulation
        1. Tablets- Market Insights and Forecast 2022-2032, USD Million
        2. Capsules- Market Insights and Forecast 2022-2032, USD Million
        3. Liquids- Market Insights and Forecast 2022-2032, USD Million
        4. Injectables- Market Insights and Forecast 2022-2032, USD Million
        5. Gels/Creams- Market Insights and Forecast 2022-2032, USD Million
        6. Patches- Market Insights and Forecast 2022-2032, USD Million
      9. By End User
        1. Hospitals- Market Insights and Forecast 2022-2032, USD Million
        2. Clinics/ASCs- Market Insights and Forecast 2022-2032, USD Million
        3. Homecare- Market Insights and Forecast 2022-2032, USD Million
      10. By Competitors
        1. Competition Characteristics
        2. Market Share & Analysis
  6. Peru Systemic Analgesics Market Statistics, 2022-2032
    1. Market Size & Growth Outlook
      1. By Revenues in USD Million
    2. Market Segmentation & Growth Outlook
      1. By Drug Type- Market Insights and Forecast 2022-2032, USD Million
      2. By Route of Administration- Market Insights and Forecast 2022-2032, USD Million
      3. By Pain Type- Market Insights and Forecast 2022-2032, USD Million
      4. By Application- Market Insights and Forecast 2022-2032, USD Million
      5. By Sales Channel- Market Insights and Forecast 2022-2032, USD Million
      6. By Prescription Type- Market Insights and Forecast 2022-2032, USD Million
      7. By Formulation- Market Insights and Forecast 2022-2032, USD Million
      8. By End User- Market Insights and Forecast 2022-2032, USD Million
  7. Peru Topical Analgesics/Anaesthetic Market Statistics, 2022-2032
    1. Market Size & Growth Outlook
      1. By Revenues in USD Million
    2. Market Segmentation & Growth Outlook
      1. By Drug Type- Market Insights and Forecast 2022-2032, USD Million
      2. By Route of Administration- Market Insights and Forecast 2022-2032, USD Million
      3. By Pain Type- Market Insights and Forecast 2022-2032, USD Million
      4. By Application- Market Insights and Forecast 2022-2032, USD Million
      5. By Sales Channel- Market Insights and Forecast 2022-2032, USD Million
      6. By Prescription Type- Market Insights and Forecast 2022-2032, USD Million
      7. By Formulation- Market Insights and Forecast 2022-2032, USD Million
      8. By End User- Market Insights and Forecast 2022-2032, USD Million
  8. Competitive Outlook
    1. Company Profiles
      1. GSK Consumer Healthcare Peru SRL
        1. Business Description
        2. Product Portfolio
        3. Collaborations & Alliances
        4. Recent Developments
        5. Financial Details
        6. Others
      2. Hersil SA Laboratorios Industriales Farmaceuticos
        1. Business Description
        2. Product Portfolio
        3. Collaborations & Alliances
        4. Recent Developments
        5. Financial Details
        6. Others
      3. Bayer SA
        1. Business Description
        2. Product Portfolio
        3. Collaborations & Alliances
        4. Recent Developments
        5. Financial Details
        6. Others
      4. Pfizer SA
        1. Business Description
        2. Product Portfolio
        3. Collaborations & Alliances
        4. Recent Developments
        5. Financial Details
        6. Others
      5. Teva Peru SA
        1. Business Description
        2. Product Portfolio
        3. Collaborations & Alliances
        4. Recent Developments
        5. Financial Details
        6. Others
      6. Maver Peru SAC
        1. Business Description
        2. Product Portfolio
        3. Collaborations & Alliances
        4. Recent Developments
        5. Financial Details
        6. Others
      7. Medifarma SA
        1. Business Description
        2. Product Portfolio
        3. Collaborations & Alliances
        4. Recent Developments
        5. Financial Details
        6. Others
      8. Farmindustria SA
        1. Business Description
        2. Product Portfolio
        3. Collaborations & Alliances
        4. Recent Developments
        5. Financial Details
        6. Others
      9. Vita Pharma SAC
        1. Business Description
        2. Product Portfolio
        3. Collaborations & Alliances
        4. Recent Developments
        5. Financial Details
        6. Others
      10. Johnson & Johnson del Peru SA
        1. Business Description
        2. Product Portfolio
        3. Collaborations & Alliances
        4. Recent Developments
        5. Financial Details
        6. Others
  9. Disclaimer
SegmentSub-Segment
By Product
  • Systemic Analgesics
    • Adult Analgesics
    • Paediatric Analgesics
    • Combined Systemic Analgesics
  • Topical Analgesics/Anaesthetic
By Drug Type
  • Opioid Analgesics
    • Strong Opioids
    • Weak Opioids
  • Non-opioid Analgesics
    • Acetaminophen
    • Aspirin
    • Combination Products
    • Diclofenac
    • Dipyrone
    • Ibuprofen
    • Ketoprofen
    • Naproxen
    • OTC Triptans
  • Compound/Combination Analgesics
    • Opioid + Non-Opioid Combinations
    • Multi-Ingredient Non-Opioid Combinations
By Route of Administration
  • Oral
  • Parenteral/Injectable
  • Topical/External
  • Transdermal
  • Rectal/Other
By Pain Type
  • Acute Pain
  • Chronic Pain
  • Breakthrough Pain
By Application
  • Surgical & Post-operative Pain
  • Musculoskeletal Pain
  • Neuropathic Pain
  • Cancer Pain
  • Migraine/Headache
  • Dental Pain
  • Others
By Sales Channel
  • Retail Offline
    • Offline Pharmacies
    • Hospital Pharmacies
  • Retail Online
    • Online Pharmacies
By Prescription Type
  • Prescription
  • OTC
By Formulation
  • Tablets
  • Capsules
  • Liquids
  • Injectables
  • Gels/Creams
  • Patches
By End User
  • Hospitals
  • Clinics/ASCs
  • Homecare

Research Methodology

This study followed a structured approach comprising four key phases to assess the size and scope of the electro-oxidation market. The process began with thorough secondary research to collect data on the target market, related markets, and broader industry context. These findings, along with preliminary assumptions and estimates, were then validated through extensive primary research involving industry experts from across the value chain. To calculate the overall market size, both top-down and bottom-up methodologies were employed. Finally, market segmentation and data triangulation techniques were applied to refine and validate segment-level estimations.

Secondary Research

The secondary research phase involved gathering data from a wide range of credible and published sources. This step helped in identifying industry trends, defining market segmentation, and understanding the market landscape and value chain.

Sources consulted during this phase included:

  • Company annual reports, investor presentations, and press releases
  • Industry white papers and certified publications
  • Trade directories and market-recognized databases
  • Articles from authoritative authors and reputable journals
  • Gold and silver standard websites

Secondary research was critical in mapping out the industry's value chain and monetary flow, identifying key market segments, understanding regional variations, and tracking significant industry developments.

Other key sources:

  • Financial disclosures
  • Industry associations and trade bodies
  • News outlets and business magazines
  • Academic journals and research studies
  • Paid industry databases

Primary Research

To validate secondary data and gain deeper market insights, primary research was conducted with key stakeholders across both the supply and demand sides of the market.

On the demand side, participants included decision-makers and influencers from end-user industries—such as CIOs, CTOs, and CSOs—who provided first-hand perspectives on market needs, product usage, and future expectations.

On the supply side, interviews were conducted with manufacturers, industry associations, and institutional participants to gather insights into current offerings, product pipelines, and market challenges.

Primary interviews provided critical inputs such as:

  • Market size and revenue data
  • Product and service breakdowns
  • Market forecasts
  • Regional and application-specific trends

Stakeholders consulted included:

  • Leading OEM and solution providers
  • Channel and distribution partners
  • End users across various applications
  • Independent consultants and industry specialists

Market Size Estimation and Data Triangulation

  • Identifying Key Market Participants (Secondary Research)
    • Goal: To identify the major players or companies in the target market. This typically involves using publicly available data sources such as industry reports, market research publications, and financial statements of companies.
    • Tools: Reports from firms like Gartner, Forrester, Euromonitor, Statista, IBISWorld, and others. Public financial statements, news articles, and press releases from top market players.
  • Extracting Earnings of Key Market Participants
    • Goal: To estimate the earnings generated from the product or service being analyzed. This step helps in understanding the revenue potential of each market player in a specific geography.
    • Methods: Earnings data can be gathered from:
      • Publicly available financial reports (for listed companies).
      • Interviews and primary data sources from professionals, such as Directors, VPs, SVPs, etc. This is especially useful for understanding more nuanced, internal data that isn't publicly disclosed.
      • Annual reports and investor presentations of key players.
  • Data Collation and Development of a Relevant Data Model
    • Goal: To collate inputs from both primary and secondary sources into a structured, data-driven model for market estimation. This model will incorporate key market KPIs and any independent variables relevant to the market.
    • Key KPIs: These could include:
      • Market size, growth rate, and demand drivers.
      • Industry-specific metrics like market share, average revenue per customer (ARPC), or average deal size.
      • External variables, such as economic growth rates, inflation rates, or commodity prices, that could affect the market.
    • Data Modeling: Based on this data, the market forecasts are developed for the next 5 years. A combination of trend analysis, scenario modeling, and statistical regression might be used to generate projections.
  • Scenario Analysis
    • Goal: To test different assumptions and validate how sensitive the market is to changes in key variables (e.g., market demand, regulatory changes, technological disruptions).
    • Types of Scenarios:
      • Base Case: Based on current assumptions and historical data.
      • Best-Case Scenario: Assuming favorable market conditions, regulatory environments, and technological advancements.
      • Worst-Case Scenario: Accounting for adverse factors, such as economic downturns, stricter regulations, or unexpected disruptions.